U.S. Diversified Financial Stock News

T. Rowe Price Group (TROW) has declared a quarterly dividend of $1.30 per share, a 2.36% increase. This marks 40 consecutive years of annual dividend growth and puts its income profile in focus for investors. See our latest analysis for T. Rowe Price Group. Despite the higher dividend, recent product launches, and earnings update, the share price at US$96.64 reflects a 30 day share price return of 9.94% and a 1 year total shareholder return decline of 6.66%. This suggests momentum has been...

Event context and why Hanover Insurance Group matters now Hanover Insurance Group (THG) is back on investors’ radars after recent trading left the shares with mixed short term performance, including a small gain over the past month and a decline over the past 3 months. At a last close of $174.42 and a reported intrinsic discount of 58.10%, the insurer’s valuation profile, alongside revenue of $6,594.4 and net income of $660.7, is drawing attention from investors comparing property and...

Alphabet’s recent performance at a glance Alphabet (GOOGL) has seen mixed share price moves recently, with a 1 day return of 1.77% decline and a 7 day return of 4.34% decline, while the past 3 months show 14.36% total return. Over longer horizons, the stock’s total return is 1.09% year to date, 74.19% over the past year, 2.31x over 3 years, and 2.03x over 5 years, giving investors a broad range of reference points. See our latest analysis for Alphabet. At a share price of US$318.58,...

Expand Energy (NasdaqGS:EXE) appointed Michael Wichterich as Interim CEO, replacing Nick Dell’Osso. The company is relocating its corporate headquarters from Oklahoma City to Houston to be closer to the U.S. energy hub. These moves mark a meaningful shift in leadership and operating base for the company, which is trading at $102.21 per share. For investors watching NasdaqGS:EXE, the leadership change comes after a mixed share price pattern, with a 35.3% return over three years and a 195.1%...

CNO Financial Group, Inc. reported past fourth-quarter 2025 revenue of US$1,143.1 million, up from US$1,097.2 million a year earlier, while net income fell to US$92.9 million and full-year earnings and earnings per share from continuing operations also declined despite slightly higher revenue. Alongside these results, CNO completed a long-running share repurchase program totaling 180,243,503 shares for about US$3.34 billions, underscoring continued capital return even as reported net income...

In recent days, J.B. Hunt Transport Services reported fourth-quarter earnings per share above analyst expectations, raised its quarterly dividend by 2.3%, and joined the Triumph Network to roll out automated payment solutions aimed at improving freight transaction efficiency. An interesting angle for investors is how J.B. Hunt’s push into automated payments aligns with its focus on operational efficiency and cost discipline across its logistics network. We’ll now examine how the earnings...

Recent backlash after Donald Trump reposted a racist video targeting Barack and Michelle Obama on Truth Social has pushed Trump Media & Technology Group (DJT) into focus. Investors are reassessing headline risk around the platform. See our latest analysis for Trump Media & Technology Group. At a share price of $11.25, Trump Media & Technology Group has seen pressure build recently, with a 30 day share price return of 21.93% decline and a 1 year total shareholder return of 62.92% decline,...

If you are wondering whether PG&E at around US$16.75 is still a smart place for your money, the key question is what you are really paying for today. The stock has moved recently, with returns of 9.2% over the last 7 days, 5.7% over the last month, 3.0% year to date, 7.0% over 1 year, 8.8% over 3 years and 43.6% over 5 years, which may have changed how the market views its risk and reward trade off. Recent headlines around PG&E have continued to focus on the company’s regulated utility role...

SiteOne Landscape Supply reported its fourth-quarter 2025 results, with sales rising to US$1,045.6 million and its quarterly net loss narrowing to US$9 million, while full-year sales reached US$4,704.8 million and net income increased to US$151.8 million. The company also improved its earnings per share from continuing operations for the full year, with diluted EPS rising from US$2.71 to US$3.37, underlining higher profitability on slightly higher revenue. We’ll now examine how this...

Ichor Holdings (ICHR) just wrapped up FY 2025 with Q4 revenue of US$223.6 million and a basic EPS loss of US$0.46, while trailing twelve month figures show revenue of US$947.7 million and a basic EPS loss of US$1.54. Over recent quarters, the company has seen quarterly revenue move between US$211.1 million and US$244.5 million, with basic EPS losses ranging from US$0.08 to US$0.67. This pattern keeps the focus squarely on how efficiently each dollar of sales is translating into earnings. With...

McKesson (NYSE:MCK) has completed its exit from European operations to focus on North American businesses. The company plans a spin-off of its medical-surgical segment as part of a broader portfolio reshaping. Oncology and specialty businesses, along with technology solutions, reported strong performance in Q3. Management raised full-year guidance following Q3 results, reflecting the new business mix and priorities. For you as an investor, McKesson now appears more concentrated around its...

If you are wondering whether Insmed at around US$148.55 is still a sensible entry or hold after a strong run, the key question is how that price compares with its underlying value. The share price has seen a 5.5% decline over the last 7 days and a 15.6% decline over the last 30 days, even though the 1 year return is 85.9% and the 3 year return is very large. Recent attention on Insmed has centered on its position in the pharmaceuticals and biotech space and how the market is weighing its...

MSCI Inc. recently reported fourth-quarter 2025 results showing sales of US$822.53 million and net income of US$284.67 million, alongside announcing a first-quarter 2026 dividend of US$2.05 per share and the completion of multi-billion-dollar share repurchase programs. At the UBS Financial Services Conference and through its latest index review, MSCI underscored its push into AI-enabled tools and high-profile index inclusions, reinforcing its role as a key infrastructure provider to global...

BETA Technologies (BETA) has drawn fresh attention after recent trading left the stock with a 1 day return of 0.30%, alongside negative moves over the past week, month, and past 3 months. See our latest analysis for BETA Technologies. The 0.30% 1 day share price return comes against a much weaker backdrop, with 7 day, 30 day, 90 day and year to date share price returns all firmly negative. This suggests recent momentum has been fading despite BETA Technologies trading at $16.77. If this shift...

Ciena Corporation ( NYSE:CIEN ) shares have continued their recent momentum with a 30% gain in the last month alone...

Verizon Communications Inc. ( NYSE:VZ ) will increase its dividend from last year's comparable payment on the 1st of...

The loanDepot, Inc. ( NYSE:LDI ) share price has fared very poorly over the last month, falling by a substantial 27...

Molina Healthcare, Inc. ( NYSE:MOH ) shares have had a horrible month, losing 31% after a relatively good period...

V.F Corporation (NYSE:VFC) has announced senior leadership changes, including appointing Brent Hyder as Chief Commercial Officer. Martino Scabbia Guerrini will move from his current role into a senior advisory position to support the leadership transition. These changes reflect an internal reshuffle of executive responsibilities affecting how the company manages its global brands and commercial operations. For investors watching V.F at a share price of $20.91, these leadership shifts come...

iRhythm Technologies, Inc. has voluntarily deregistered its Common Stock. The company has completed a holding company reorganization. iRhythm Holdings, Inc. now serves as the new public entity for shareholders. The changes affect the stock associated with NasdaqGS:IRTC and the prior operating company. iRhythm focuses on cardiac monitoring solutions, so any change in its corporate structure tends to attract attention from investors who follow medical technology names. The move to a holding...

Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.52 on 6th of...

If you are wondering whether Tesla's current share price lines up with its underlying value, you are not alone. This article walks through what the numbers are actually saying. Tesla closed at US$425.21, with returns of 0.8% over the last week, a 4.4% decline over the last month, a 2.9% decline year to date, and a 29.4% gain over the past year, while the 3 year return is 103.2% and the 5 year return is 60.2%. Recent headlines around Tesla have focused on the broader electric vehicle sector,...

Incyte's drug Zynyz received a positive opinion from the European Medicines Agency's CHMP for use with chemotherapy as a first line treatment for metastatic or inoperable squamous cell carcinoma of the anal canal. The recommendation supports potential use of Zynyz in adult patients across the European Union, subject to final regulatory approval. For investors watching NasdaqGS:INCY, this regulatory progress comes with the stock trading at $100.05 and a 1 year return of 50.8%. Over 3 and 5...

Recent figures for Vita Coco Company (COCO) have caught investor attention, with unit sales rising 10.8% over the past two years and earnings per share growing 89.3% annually over the last three years. See our latest analysis for Vita Coco Company. Despite strong fundamentals, the recent 1 day share price return of a 3.17% decline and 1 week share price return of a 1.74% decline contrast with a 90 day share price return of 31.11% and a 1 year total shareholder return of 43.48%. This suggests...